Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

D (+) -Maltose (Biotechnology Grade)

<strong>D(+)-Maltose</strong>_x000D_ <strong>Catalog number:</strong> B2010056_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Volume/Weight:</strong> 100 g_x000D_ <strong>pH:</strong> na_x000D_ <strong>Supplied as:</strong> Ready-to-use_x000D_ <strong>Appearance:</strong> White Powder_x000D_ <strong>Applications:</strong> multipurpose sugar with applications in cell culture, reagent formulation, reagent stabilization and more._x000D_ <strong>Storage:</strong> Room temperature_x000D_ <strong>Keywords:</strong> maltose_x000D_ <strong>Grade:</strong> Biotechnology grade. All components are highly pure (minimum 99%). All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered on a 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Breyton C, Javed W, Vermot A, Arnaud CA, Hajjar C, Dupuy J, Petit-Hartlein I,_x000D_ Le Roy A, Martel A, Thépaut M, Orelle C, Jault JM, Fieschi F, Porcar L, Ebel C._x000D_ Assemblies of lauryl maltose neopentyl glycol (LMNG) and LMNG-solubilized_x000D_ membrane proteins. Biochim Biophys Acta Biomembr. 2019 May 1;1861(5):939-957._x000D_ _x000D_ 2: Mishra V, Roy P, Gandhi K, Choudhary S, Aggarwal R, Sokabaj S. Safety and_x000D_ Efficacy of Intravenous Ferric Carboxy Maltose in Iron Deficiency Anaemia During_x000D_ Post-partum Period. J Nepal Health Res Counc. 2018 Jan 1;15(3):208-211._x000D_ _x000D_ 3: Adkinson NF, Strauss WE, Macdougall IC, Bernard KE, Auerbach M, Kaper RF,_x000D_ Chertow GM, Krop JS. Comparative safety of intravenous ferumoxytol versus ferric_x000D_ carboxymaltose in iron deficiency anemia: A randomized trial. Am J Hematol. 2018_x000D_ May;93(5):683-690._x000D_ _x000D_ 4: Froessler B, Gajic T, Dekker G, Hodyl NA. Treatment of iron deficiency and_x000D_ iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy. Arch_x000D_ Gynecol Obstet. 2018 Jul;298(1):75-82._x000D_ _x000D_ 5: Ghosh A, Smith PES, Qin S, Yi M, Zhou HX. Both Ligands and Macromolecular_x000D_ Crowders Preferentially Bind to Closed Conformations of Maltose Binding Protein._x000D_ Biochemistry. 2019 Apr 30;58(17):2208-2217._x000D_ _x000D_ 6: Chu Z, Zhang L, Zhang W. Preparation and evaluation of maltose modified_x000D_ polymer-silica composite based on cross-linked poly glycidyl methacrylate as_x000D_ high performance liquid chromatography stationary phase. Anal Chim Acta. 2018_x000D_ Dec 7;1036:179-186._x000D_ _x000D_ 7: He D, Zhou J, Xia Q, Jiang L, Qiu Y, Zhao L. Kinetics and equilibria of the_x000D_ chromatographic separation of maltose and trehalose. J Sep Sci. 2015_x000D_ Jul;38(13):2229-37._x000D_ _x000D_ 8: Qassim A, Mol BW, Grivell RM, Grzeskowiak LE. Safety and efficacy of_x000D_ intravenous iron polymaltose, iron sucrose and ferric carboxymaltose in_x000D_ pregnancy: A systematic review. Aust N Z J Obstet Gynaecol. 2018_x000D_ Feb;58(1):22-39._x000D_ _x000D_ 9: Khalafallah AA, Hyppa A, Chuang A, Hanna F, Wilson E, Kwok C, Yan C, Gray Z,_x000D_ Mathew R, Falloon P, Dennis A, Pavlov T, Allen JC. A Prospective Randomised_x000D_ Controlled Trial of a Single Intravenous Infusion of Ferric Carboxymaltose vs_x000D_ Single Intravenous Iron Polymaltose or Daily Oral Ferrous Sulphate in the_x000D_ Treatment of Iron Deficiency Anaemia in Pregnancy. <a href="https://pubmed.ncbi.nlm.nih.gov/30502851/">Semin Hematol.</a> 2018_x000D_ Oct;55(4):223-234._x000D_ _x000D_ <strong>Products Related to D(+)-Maltose </strong> <a>: Biochemical Buffers and Solutions</a>

Product Specifications

Short Description

Catalog Number: B2010056 (100 g)

Weight

5.5

Length

5

Width

3

Height

3

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

CD45RO (190-2F2.5), CF488A conjugate, 0.1mg/mL
BNC881081-500 1x 500 µL

CD45RO (190-2F2.5), CF488A conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Cytokeratin, LMW (AE-1), CF594 conjugate, 0.1mg/mL
BNC940253-100 1x 100 µL

Cytokeratin, LMW (AE-1), CF594 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD71 (66IG10), CF405S conjugate, 0.1mg/mL
BNC040871-500 1x 500 µL

CD71 (66IG10), CF405S conjugate, 0.1mg/mL

Sign In for Pricing
View Details
MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (VU-11D1), CF647 conjugate, 0.1mg/mL
BNC470965-500 1x 500 µL

MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (VU-11D1), CF647 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
UACA / Nucling (AE-5), CF594 conjugate, 0.1mg/mL
BNC940956-100 1x 100 µL

UACA / Nucling (AE-5), CF594 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
VEGF (Vascular Endothelial Growth Factor) (VG76e), CF647 conjugate, 0.1mg/mL
BNC471687-500 1x 500 µL

VEGF (Vascular Endothelial Growth Factor) (VG76e), CF647 conjugate, 0.1mg/mL

Sign In for Pricing
View Details